Open TAP-block in Pediatric Abdominal Surgery

January 12, 2026 updated by: Uppsala University

TAP-blockad Vid öppen Bukkirurgi Hos Barn

The goal of this trial is to evaluate an open TAP-block vs continuous administration of local anestetic via a wound catheter for postoperative pain management in patients 1-15 years of age undergoing open abdominal surgery.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 1-15 years
  • Scheduled for elective or acute open adominal surgical procedure

Exclusion Criteria:

  • chronic abdominal pain
  • known allergy to local analgetic
  • Stage 4 renal failure
  • psychiatric ailnment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAP-block
Subjects in the TAP-block arm will recieve an open TAP-block at the end of the procedure vbefore wound closure
Open TAP(transverse abdominal plane)-block placed by the surgeon using open technique at end of surgery before wound closure
Active Comparator: Wound infiltration
Subjects in the wound infiltration group will recieve contionious administration of local anastethic via a wound catheter placed subcutaneousley during wound closure.
A catheter placed subcutainiousley for the continuous administration of local anestethic in the wound for up to 3 days post-op

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative opiates
Time Frame: during the first 24 hours following surgery and total opioids until discarge up to 14 days postoperative
Amount of postoperative opiates administered
during the first 24 hours following surgery and total opioids until discarge up to 14 days postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lenght of stay
Time Frame: Days from surgery through study completeion, an average expected time of7 days
Duration of hospital stay
Days from surgery through study completeion, an average expected time of7 days
Pain assessment
Time Frame: End of surgery until 24 hours post-op
Pain assesment using validated instruments, FLACC or FPS-R
End of surgery until 24 hours post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Oskar Nensén, MD, PhD, Uppsala University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Study Registration Dates

First Submitted

December 2, 2025

First Submitted That Met QC Criteria

January 12, 2026

First Posted (Actual)

January 20, 2026

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 12, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NOR001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD (anonymized) underlying data in a future publication will be made available on request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain Management After Surgery

Clinical Trials on TAP-block

Subscribe